1.33 USD
▼-0.10-6.99%
盘后 1.33 +0.35%
2026-09-15
市值
$188.49M
市盈率
0.95
EPS
-1.00
股息率
—
52 周区间
1.09 – 2.62
成交量
761.96K
Beta
0.94
目标价
7.75
52W 低 1.0952W 高 2.62
价格走势
公司简介
Coherus Oncology, Inc., a biopharmaceutical company, researches, develops, and commercializes immunotherapies to treat cancer in the United States. The company develops UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte-colony stimulating factor; LOQTORZI, a novel next-generation programmed death receptor-1 inhibitor; and Casdozokitug, an investigational recombinant human immunoglobulin isotype (IgG1) monoclonal antibody targeting interleukin IL-27. It also develops CHS-114, an investigational human afucosylated IgG1 monoclonal antibo...